Fred Hutch researchers have launched a clinical trial for patients with HIV who need a transplant to survive advanced leukemia. They will receive a transplant of cord blood from donors who have a rare genetic trait that confers resistance to HIV, in hopes of curing both leukemia and HIV. The protocol is similar to that used in 2017 with a New York patient who last month was declared the third person ever cured of HIV.